Mesco Pharmaceuticals Limited SHARE PRICE [LIVE]
What is not working for the company?
What is working for the company?
|Name||Sep 19||Jun 19|
|Mutual Funds (Change:0.00)||0%||0%|
|Insurance Companies (Change:0.00)||0%||0%|
|Other DIIs (Change:0.00)||0%||0%|
|Non Institution (Change:0.00)||60.7%||60.7%|
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Mesco Pharmaceuticals Limited
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
Frequently Asked Questions
Can I buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares?
How do I buy Mesco Pharmaceuticals Limited (MESCOPHARM) from Angel One?
- Direct investment: You can buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Mesco Pharmaceuticals Limited (MESCOPHARM) shares.
Today's live share price for Mesco Pharmaceuticals Limited is NSE: N/A, BSE: N/A with a current market capitalization of .
Mesco Pharmaceuticals started commercial operations in Jun.'91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bulk drugs and formulations. It set up a formulation plant to manufacture injectables, syrups, ointments and tablets/capsules. The company in technical partnership with Merz, Germany, introduced two drugs -- Hepa Merz and Viru Merz -- for hepatitis (liver disorder) and herpes respectively. It is now developing drugs for cardio-vascular diseases and Parkinson's disease. Apart from Merz, Mesco has technical agreements with two Chinese companies -- Guilin Pharmaceutical Factory and China Science & Resources Technology Trading Corporation. The company has expanded its marketing network to the CIS, Italy, Germany and Africa. It is setting up a multi-purpose bulk drug plant with sterile technology to manufacture the latest bulk drugs, in technical collaboration with Chementechno, Austria. During 1996-97, the company earned foreign exchange worth Rs 1.25 cr.Read more